Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 1,000 shares at $57.64 ($58K) on 2018-09-07, disclosed to the SEC on 2018-09-07.
Open-market sale of $58k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |
| BSTC | SELL | 2015-06-25 | $1.9M | — | Filing → |